Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The expression, function, and clinical relevance of B7 family members in cancer.

Seliger B, Quandt D.

Cancer Immunol Immunother. 2012 Aug;61(8):1327-41. doi: 10.1007/s00262-012-1293-6. Epub 2012 Jun 14. Review.

PMID:
22695874
2.

T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.

Lu B, Chen L, Liu L, Zhu Y, Wu C, Jiang J, Zhang X.

Immunol Res. 2011 Aug;50(2-3):269-75. doi: 10.1007/s12026-011-8227-9.

PMID:
21717068
3.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Peggs KS, Quezada SA, Allison JP.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Review.

PMID:
18759925
4.

B7-h3 and its role in antitumor immunity.

Loos M, Hedderich DM, Friess H, Kleeff J.

Clin Dev Immunol. 2010;2010:683875. doi: 10.1155/2010/683875. Epub 2010 Nov 28. Review.

5.

[Lymphocyte coreceptors].

Olive D.

Med Sci (Paris). 2006 Dec;22(12):1069-74. Review. French.

6.

B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.

Kaifu T, Escalière B, Gastinel LN, Vivier E, Baratin M.

Cell Mol Life Sci. 2011 Nov;68(21):3531-9. doi: 10.1007/s00018-011-0802-7. Epub 2011 Aug 30. Review.

PMID:
21877119
7.

Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Podojil JR, Miller SD.

BioDrugs. 2013 Feb;27(1):1-13. doi: 10.1007/s40259-012-0001-6. Review.

8.
9.
10.

The balance of immune responses: costimulation verse coinhibition.

Subudhi SK, Alegre ML, Fu YX.

J Mol Med (Berl). 2005 Mar;83(3):193-202. Epub 2005 Jan 4. Review.

PMID:
15630593
11.

Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.

Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.

Eur J Immunol. 1998 Jan;28(1):90-103.

12.

The B7 homologues and their receptors in hematologic malignancies.

Wilcox RA, Ansell SM, Lim MS, Zou W, Chen L.

Eur J Haematol. 2012 Jun;88(6):465-75. doi: 10.1111/j.1600-0609.2012.01766.x. Epub 2012 Feb 28. Review.

13.

Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis?

Gerdes N, Zirlik A.

Thromb Haemost. 2011 Nov;106(5):804-13. doi: 10.1160/TH11-09-0605. Epub 2011 Oct 6. Review.

PMID:
21979444
14.

[Dendritic cells and immune function in cancer].

Chaux P.

Pathol Biol (Paris). 1995 Dec;43(10):897-903. Review. French.

PMID:
8786896
15.

B7-H3-mediated tumor immunology: Friend or foe?

Wang L, Kang FB, Shan BE.

Int J Cancer. 2014 Jun 15;134(12):2764-71. doi: 10.1002/ijc.28474. Epub 2013 Sep 30. Review.

16.

Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.

Brunner A, Hinterholzer S, Riss P, Heinze G, Brustmann H.

Gynecol Oncol. 2012 Jan;124(1):105-11. doi: 10.1016/j.ygyno.2011.09.012. Epub 2011 Oct 6.

PMID:
21982044
17.
18.

B7-H abnormalities in melanoma and clinical relevance.

Seliger B.

Methods Mol Biol. 2014;1102:367-80. doi: 10.1007/978-1-62703-727-3_19.

PMID:
24258988
19.

The B7 family and cancer therapy: costimulation and coinhibition.

Zang X, Allison JP.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5271-9. Review.

20.

Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection.

Luan Y, Ju J, Luo L, Zhang Z, Wang J, Zhu DM, Cheng L, Zhang SY, Chen L, Wang FS, Wang S.

J Viral Hepat. 2012 Jan;19(1):23-31. doi: 10.1111/j.1365-2893.2010.01421.x. Epub 2011 Mar 29.

PMID:
22187944

Supplemental Content

Support Center